
Ked Thavorn
Related Authors
Joachim Sturmberg
Monash University
António B. Moniz
Universidade Nova de Lisboa
Alexandre Chan
National University of Singapore
Armando Marques-Guedes
UNL - New University of Lisbon
Prashanth Nuggehalli Srinivas
Institute of Public Health, Bangalore
Cesar A Galvez
Adventist International Institute of Advanced Studies
Surendra Gupta
Banaras Hindu University, Varanasi
Ehab Sorketti
University of Malaya, Malaysia
ELCHİN SULEYMANOV
Azerbaijan National Academy of Sciences
Akram Ahmad
The University of Sydney
InterestsView All (6)
Uploads
Papers by Ked Thavorn
including antihypertensive effect, prevention and treatment of urinary tract infection, anti-oxidation, and anti-atherosclerotic effect
have been reported. However, since the results from studies were inconclusive, a conclusion on whether Hibiscus sabdariffa
possesses such beneficial effects is highly needed. This study aimed to examine the efficacy and tolerability of Hibiscus
sabdariffa compared to other interventions in randomized controlled trials by means of a systematic review. We searched
studies and relevant information from Medline (1966-2006), Cumulative Index to Nursing Allied Health Literature (CINAHL)
(1982-2006), International Pharmaceutical Abstracts (IPA) (1970 – 2006), Current Content, Cochrane Library, and Thai Index
Medicus, bibliographies of retrieved articles and experts in the field.
There were 66 clinical trials examining effects of Hibiscus sabdariffa. We found five trials studying the efficacy of Roselle
on human; however, only two were randomized controlled trials. These two studies were included in our present study. The first
trial tested antihypertensive effect of the tea of dried calyx of Hibiscus sabdariffa compared with captopril (25 mg every 12
hours) in patients with mild to moderate hypertension. The study found no difference regarding efficacy and tolerability between
Hibiscus sabdariffa tea and captopril. The second study reported that at day 12 of the treatment, sour tea (the tea made from
Hibiscus sabdariffa) significantly reduced both systolic and diastolic blood when compared with baseline (P < 0.01). The two
studies included in this systematic review had a relatively low quality (Jadad’s score of 2 for both). In conclusion, the
antihypertensive effect of Hibiscus sabdariffa is somewhat evident but well conducted randomized controlled trials are highly
needed to confirm such antihypertensive effect, and to examine also its other clinical benefits
including antihypertensive effect, prevention and treatment of urinary tract infection, anti-oxidation, and anti-atherosclerotic effect
have been reported. However, since the results from studies were inconclusive, a conclusion on whether Hibiscus sabdariffa
possesses such beneficial effects is highly needed. This study aimed to examine the efficacy and tolerability of Hibiscus
sabdariffa compared to other interventions in randomized controlled trials by means of a systematic review. We searched
studies and relevant information from Medline (1966-2006), Cumulative Index to Nursing Allied Health Literature (CINAHL)
(1982-2006), International Pharmaceutical Abstracts (IPA) (1970 – 2006), Current Content, Cochrane Library, and Thai Index
Medicus, bibliographies of retrieved articles and experts in the field.
There were 66 clinical trials examining effects of Hibiscus sabdariffa. We found five trials studying the efficacy of Roselle
on human; however, only two were randomized controlled trials. These two studies were included in our present study. The first
trial tested antihypertensive effect of the tea of dried calyx of Hibiscus sabdariffa compared with captopril (25 mg every 12
hours) in patients with mild to moderate hypertension. The study found no difference regarding efficacy and tolerability between
Hibiscus sabdariffa tea and captopril. The second study reported that at day 12 of the treatment, sour tea (the tea made from
Hibiscus sabdariffa) significantly reduced both systolic and diastolic blood when compared with baseline (P < 0.01). The two
studies included in this systematic review had a relatively low quality (Jadad’s score of 2 for both). In conclusion, the
antihypertensive effect of Hibiscus sabdariffa is somewhat evident but well conducted randomized controlled trials are highly
needed to confirm such antihypertensive effect, and to examine also its other clinical benefits